Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 08, 2022

SELL
$59.26 - $71.14 $285,514 - $342,752
-4,818 Closed
0 $0
Q1 2022

May 06, 2022

SELL
$55.72 - $67.12 $146,822 - $176,861
-2,635 Reduced 35.35%
4,818 $320,000
Q4 2021

Feb 07, 2022

SELL
$54.02 - $63.83 $80,813 - $95,489
-1,496 Reduced 16.72%
7,453 $434,000
Q3 2021

Nov 09, 2021

SELL
$55.56 - $60.79 $193,293 - $211,488
-3,479 Reduced 27.99%
8,949 $537,000
Q2 2021

Aug 11, 2021

BUY
$48.42 - $60.18 $51,470 - $63,971
1,063 Added 9.35%
12,428 $744,000
Q1 2021

May 14, 2021

BUY
$47.16 - $54.44 $535,973 - $618,710
11,365 New
11,365 $565,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Koss Olinger Consulting, LLC Portfolio

Follow Koss Olinger Consulting, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Koss Olinger Consulting, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Koss Olinger Consulting, LLC with notifications on news.